Spyridon Savvanis

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

Evdoxia Kyriazopoulou, Haralampos Milionis, Symeon Metallidis et al. · Nature Medicine · 2021 · 539 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Complications of the Type 2 Diabetes Mellitus

Paraskevi Farmaki, Christos Damaskos, Nikolaos Garmpis et al. · Current Cardiology Reviews · 2021 · 173 citations · Full text

Medicine, Endocrinology, Internal Medicine +13

Sildenafil Attenuates Hepatocellular Injury after Liver Ischemia Reperfusion in Rats: A Preliminary Study

Spyridon Savvanis, Constantinos Nastos, Marios Konstantinos Tasoulis et al. · Oxidative Medicine and Cellular Longevity · 2014 · 32 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The Impact of Peripheral Eosinophil Counts and Eosinophil to Lymphocyte Ratio (ELR) in the Clinical Course of COVID-19 Patients: A Retrospective Study

Vasiliki Georgakopoulou, Nikolaos Garmpis, Christos Damaskos et al. · In Vivo · 2021 · 29 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +11

Wilson disease: 30-year data on epidemiology, clinical presentation, treatment modalities and disease outcomes from two tertiary Greek centers

Maria Tampaki, Nikolaos Gatselis, Spyridon Savvanis et al. · European Journal of Gastroenterology & Hepatology · 2020 · 14 citations

Medicine, Clinical Sciences, Genetics +17